Immediate Implant Placement Using Xenograft Mixed with Vitamin D Versus Hyaluronic Acid.
Launched by CAIRO UNIVERSITY · Feb 19, 2025
Trial Information
Current as of July 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new approach to dental implant placement. Specifically, researchers are comparing two methods of filling space after an immediate dental implant is placed: one using a material called xenograft mixed with vitamin D and the other using hyaluronic acid. The goal is to see which method helps the implant become more stable and improves the surrounding bone density, particularly in the back part of the lower jaw.
To participate in this trial, you need to be between 18 and 60 years old and generally healthy. You should be looking to get single or multiple dental implants in the back teeth area, and your jaw should have enough bone for the procedure. However, if you're a heavy smoker, have certain medical conditions that could affect surgery, or have psychological issues, you may not be eligible. If you join the trial, you'll help researchers learn more about how to improve dental implant procedures, and you can expect to be closely monitored during the process to ensure your safety and health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age: 18-60.
- • Systemically healthy patients indicated for single or multiple immediate implants in posterior teeth region.
- • Absence of any peri-apical pathosis.
- • Patients with intact buccal plate of bone.
- • Patients with adequate bone volume for the dental implant procedure.
- • Patient with good oral hygrine
- Exclusion Criteria:
- • Heavy Smokers.
- • Systemic disease that may affect the final outcome of the surgical procedure.
- • No or poor patient's compliance.
- • Patients with psychological problems.
- • Pathology at the site of intervention.
- • Patient with vit d deficiency
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported